mci-196 has been researched along with Hyperlipoproteinemia Type II in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inazu, A; Kawashiri, MA; Kobayashi, J; Mabuchi, H; Miyashita, K; Nakajima, K; Nohara, A; Tada, H; Yamagishi, M | 1 |
Miyamori, I; Suzuki, J; Takahashi, S; Zenimaru, Y | 1 |
Fujino, N; Hayashi, K; Inazu, A; Kawashiri, MA; Kobayashi, J; Konno, T; Mabuchi, H; Mori, M; Nakanishi, C; Noguchi, T; Nohara, A; Tada, H; Yamagishi, M | 1 |
Higashikata, T; Inazu, A; Kawashiri, MA; Kobayashi, J; Koizumi, J; Mabuchi, H; Nohara, A | 1 |
Homma, Y; Kobayashi, T; Nakamura, H; Ozawa, H; Sakane, H; Yamaguchi, H | 1 |
4 trial(s) available for mci-196 and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy.
Topics: Adult; Aged; Anticholesteremic Agents; Drug Therapy, Combination; Epichlorohydrin; Ezetimibe; Female; Humans; Hyperlipoproteinemia Type II; Imidazoles; Lipase; Lipoprotein Lipase; Male; Middle Aged; Receptors, LDL; Resins, Synthetic; Rosuvastatin Calcium | 2016 |
Efficacy and safety of coadministration of rosuvastatin, ezetimibe, and colestimide in heterozygous familial hypercholesterolemia.
Topics: Aged; Aged, 80 and over; Anion Exchange Resins; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epichlorohydrin; Ezetimibe; Female; Fluorobenzenes; Follow-Up Studies; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Imidazoles; Male; Middle Aged; Prospective Studies; Pyrimidines; Resins, Synthetic; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome | 2012 |
Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH).
Topics: Anion Exchange Resins; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Drug Therapy, Combination; Epichlorohydrin; Female; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Imidazoles; Japan; Male; Middle Aged; Pyrroles; Resins, Synthetic | 2005 |
Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Apolipoproteins; Bile Acids and Salts; Carrier Proteins; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, LDL; Glycoproteins; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, IDL; Lipoproteins, LDL; Molecular Weight; Phosphatidylcholine-Sterol O-Acyltransferase; Receptors, LDL; Triglycerides | 1997 |
1 other study(ies) available for mci-196 and Hyperlipoproteinemia Type II
Article | Year |
---|---|
[A case of type 2 diabetes mellitus associated with familial hypercholesterolemia confirming the improvement of blood glucose control by colestimide].
Topics: Aged; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Humans; Hyperlipoproteinemia Type II; Imidazoles; Resins, Synthetic | 2009 |